DOI: 10.1055/s-00000142

Frauenheilkunde up2date

References

Oza AM, Cook AD, Pfisterer J. et al.
Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial.

Lancet Oncol 2015;
16: 928-936

Download Bibliographical Data

Access:
Access: